Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Other Publications
    • ajnr

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.


AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

Research ArticleADULT BRAIN

A Potential Biomarker in Amyotrophic Lateral Sclerosis: Can Assessment of Brain Iron Deposition with SWI and Corticospinal Tract Degeneration with DTI Help?

R. Sheelakumari, M. Madhusoodanan, A. Radhakrishnan, G. Ranjith and B. Thomas
American Journal of Neuroradiology February 2016, 37 (2) 252-258; DOI: https://doi.org/10.3174/ajnr.A4524
R. Sheelakumari
aFrom the Department of Neurology (R.S., M.M., A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Madhusoodanan
aFrom the Department of Neurology (R.S., M.M., A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Radhakrishnan
aFrom the Department of Neurology (R.S., M.M., A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Ranjith
bDevices Testing Laboratory, Biomedical Technology Wing (G.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Thomas
cDepartment of Imaging Sciences and Interventional Radiology (B.T.), Sree Chitra Thirunal Institute of Medical Sciences and Technology, Trivandrum, Kerala, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

BACKGROUND AND PURPOSE: Iron-mediated oxidative stress plays a pivotal role in the pathogenesis of amyotrophic lateral sclerosis. This study aimed to assess iron deposition qualitatively and quantitatively by using SWI and microstructural changes in the corticospinal tract by using DTI in patients with amyotrophic lateral sclerosis.

MATERIALS AND METHODS: Seventeen patients with amyotrophic lateral sclerosis and 15 age- and sex-matched controls underwent brain MR imaging with SWI and DTI. SWI was analyzed for both signal-intensity scoring and quantitative estimation of iron deposition in the anterior and posterior banks of the motor and sensory cortices and deep gray nuclei. The diffusion measurements along the corticospinal tract at the level of pons and medulla were obtained by ROI analysis.

RESULTS: Patients with amyotrophic lateral sclerosis showed reduced signal-intensity grades in the posterior bank of the motor cortex bilaterally. Quantitative analysis confirmed significantly higher iron content in the posterior bank of the motor cortex in patients with amyotrophic lateral sclerosis. In contrast, no significant differences were noted for the anterior bank of the motor cortex, anterior and posterior banks of the sensory cortex, and deep nuclei. Receiver operating characteristic comparison showed a cutoff of 35μg Fe/g of tissue with an area under the curve of 0.78 (P = .008) for the posterior bank of the motor cortex in discriminating patients with amyotrophic lateral sclerosis from controls. Fractional anisotropy was lower in the pyramidal tracts of patients with amyotrophic lateral sclerosis at the pons and medulla on either side, along with higher directionally averaged mean diffusivity values. The combination of SWI and DTI revealed an area under the curve of 0.784 for differentiating patients with amyotrophic lateral sclerosis from controls.

CONCLUSIONS: Measurements of motor cortex iron deposition and diffusion tensor parameters of the corticospinal tract may be useful biomarkers for the diagnosis of clinically suspected amyotrophic lateral sclerosis.

ABBREVIATIONS:

ALS
amyotrophic lateral sclerosis
CST
corticospinal tract
Dav
directionally averaged mean diffusivity
FA
fractional anisotropy
PBMC
posterior bank of the motor cortex

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder of the motor system characterized by progressive degeneration of corticospinal tracts, brain stem, and lower motor neurons in the spinal cord.1,2 The clinical presentation of ALS includes progressive involvement of the upper motor neuron, lower motor neuron, and craniobulbar musculature due to degeneration of the anterior horn cells and motor neurons. The disease shows great variation in its onset, clinical presentation, and survival, with diagnosis usually depending on changes in needle electromyography from various muscles sampled, which include even the tongue and paraspinal muscles. Needle electromyography is invasive and rather cumbersome to perform. Hence, a reliable and objective noninvasive surrogate biomarker of motor neuron dysfunction, if available, may play a pivotal role in the diagnosis and monitoring of disease progression in ALS.

Recent investigations proved that ALS pathology is associated with abnormal iron homeostasis inducing excessive oxidative stress in the motor neurons.3,4 There is also evidence to suggest that reduced fractional anisotropy (FA) and increased directionally averaged mean diffusivity (Dav) along the pyramidal tracts indicate microstructural tissue changes in ALS.5⇓–7 Hence, detection of elevated iron levels in the motor cortex and associated corticospinal tract (CST) degeneration in these patients could be useful for demonstrating the underlying pathology.

MR imaging techniques that can quantify this tissue iron include T2, T2*, magnetic field correlation, field-dependent relaxation rate increase, and SWI.8⇓⇓⇓⇓⇓–14 Recent studies advocated SWI as a potential in vivo marker to detect susceptibility changes among tissues, which aids in the identification of paramagnetic nonheme iron (ferritin and transferrin), which would appear hyperintense on filtered phase images.15⇓⇓–18 These finding opened a new window to estimate the regional changes in iron content associated with ALS. The aim of this study was to measure iron in various GM regions in ALS by using qualitative and quantitative SWI and to investigate the microstructural tissue changes in CST by DTI.

Materials and Methods

Study Participants

The study was approved by the Institutional Ethics Committee. Seventeen patients (7 men and 10 women) with definite or probable ALS according to revised EI Escorial criteria19 were included in this retrospective analysis. All had undergone a detailed clinical and psychometric evaluation to exclude any associated neurologic conditions. We have subclassified the cohort (On-line Table) according to the latest phenotypic classification of ALS by Chiò et al,20 though the staging proposed by Roche et al21 was not possible in this retrospective cohort. Clinical and imaging data were retrieved from the electronic medical records and PACS, respectively. Imaging and demographic data of 15 age- and sex-matched healthy volunteers (8 men, 7 women) were also included from another prospective Institutional Ethics Committee–approved study (R. Sheelakumari, MPhil, unpublished data, 2014).

Image Acquisition

MR imaging was performed on a 1.5T (Avanto; Siemens, Erlangen, Germany) whole-body scanner by using a transmit-receive head coil array with 12 elements. All participants had undergone multisection diffusion tensor imaging by using a single-shot spin-echo echo-planar sequence. For the acquisition, diffusion sensitizing gradients were applied in 30 noncollinear directions with the following imaging parameters: TR, 6000 ms; TE, 88 ms; matrix, 128 × 128; FOV, 230 mm; 3-mm section thickness with a 1.5-mm gap averaged twice with b-values of 0 and 1000 s/mm2.

SWI was obtained with a 3D spoiled gradient recalled-echo sequence (TR/TE, 49 ms/40 ms; flip angle, 20°; section thickness, 2.1 mm; number of sections, 56; matrix, 260 × 320). We selected both SWI and corrected phase images for the analysis. In the corrected phase images, there is a direct correlation between the phase and iron content of the tissue.

For left-hand MR systems, the phase is given by the following relation: Embedded Image where γ, ΔB, TE represents the gyromagnetic ratio, the magnetic field change between tissues, and echo time, respectively. Iron being a paramagnetic element, it aligns with the main magnetic field and thus creates a positive ΔB. Thus, the larger the iron content in the tissue, the larger will be the value of ΔB and thus the larger the phase change ϕ will be relative to its surroundings. Embedded Image where Δχ is the change in susceptibility and c is the concentration of iron.

Our MR imaging processing uses the phase convention Embedded Image where Φ varies from −π to +π and φ varies from 0 to 4096. We take 180 U (0.276 radians) of phase to be equivalent to 60 μg Fe/g of tissue.13,15 The iron content is then given by the relation Embedded Image A simplification of the above equation shows that 3 Siemens phase units are equal to 1 μg Fe/g tissue.14,15 The phase images obtained were high-pass-filtered by a 64 × 64 k-space filter and resulted in an SWI filtered phase image.

Image Analysis

Qualitative Assessment of SWI.

All the SWI was visually examined in the regular clinical settings by an experienced neuroradiologist (B.T.) and a neurologist (A.R.) with >15 years of experience in their respective fields. Qualitative visual rating scores were assigned at the posterior bank of the motor cortex (PBMC), globus pallidus, putamen, and caudate nucleus. The central sulcus was used as an anatomic landmark to identify the motor cortex. Each observation was independent and blinded to the diagnosis (patients or controls). The magnitude of hypointensity was graded as 0 = absent, 1 = present (mild to moderate), 2 = present (marked) (Fig 1).

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Motor cortex hypointensity visual scoring on SWI: absent (grade 0) (A), mild to moderately present (grade 1) (B), and severely present (grade 2) (C).

Quantitative Regional Assessment of Iron Content (Microgram Iron/Gram of Tissue).

ROI-based quantitative analysis of regional iron (Fe) content was performed by using Signal Processing In NMR software (SPIN; MR Imaging Institute for Biomedical Research, Detroit, Michigan). The ROIs were drawn manually by 2 doctoral scholars (R.S. and M.M.), who were trained in the procedure. The images were magnified 2 times, and the phase values obtained from 9 structures in both hemispheres included the following: GM at the PBMC, adjacent subcortical WM and CSF in the central sulcus, GM of anterior bank of the motor cortex, anterior bank of the sensory cortex, posterior bank of the sensory cortex, and basal ganglia regions (On-line Fig 1), with extreme care to minimize partial volume effects. For all the subjects, phase values were measured by the 2 observers to determine the interobserver agreement.

The ROIs were copied to phase images to obtain the mean phase shift values within. To compare data across patients, we assumed that the CSF in each patient contained zero iron.14 Thus the iron content in an ROI was directly proportional to the shift in phase between the CSF and the particular ROI. Mean phase shift values were calculated for each ROI by averaging the values obtained from both hemispheres.

DTI ROI Analysis of CST.

DTI data were transferred to a Leonardo workstation (Siemens) and postprocessed with Neuro3D software (Siemens). The off-line tensor images and color maps were generated by using the built-in “DTI Task Card” (Version 1). T1-weighted images were coregistered on the color maps for selecting the ROI in the specific anatomic region. The datasets were then analyzed by 2 observers blinded to patients or controls. On the basis of the prior anatomic knowledge and relevant literature,5,22 2 circular ROIs of same size, 3 mm2, were placed along the CST on FA and Dav maps in the brain stem at the level of cerebellar peduncles and medullary pyramids (On-line Fig 2); care was taken to exclude non-structure-of-interest pixels. The FA and Dav values were calculated on a pixel-by-pixel basis, and average values for each position on both sides were tabulated for statistical analysis.

Statistical Analysis

Statistical analyses of all datasets were performed by using SPSS, Version 20.0 (IBM, Armonk, New York). We used the Student t test and χ2 test, respectively, to compare age and sex distributions between patients and controls. Interrater agreement of visual scoring of the hypointensity of gray matter on SWI was determined by κ statistics. To investigate whether the visual rating is effective to discriminate between groups of hypointensity scores on SWI (absent versus present, ie, group 0 versus groups 1 + 2), we performed sensitivity and specificity analysis by using crosstabs. Analyses were also repeated for the absent or mild to moderately present group versus the markedly present group (ie, 0 + 1 versus group 2). The combined hemispheric mean values of iron in micrograms/gram and FA and Dav values of each ROI were compared between subjects with ALS and controls by using the Mann-Whitney U test for independent samples with Bonferroni correction for multiple comparisons. In addition, we compared the estimated means of iron values in the posterior motor cortex with the visual rating score by using 1-way ANOVA. Furthermore, the correlation between quantitative iron and diffusion values in the CST was performed by the Pearson correlation coefficient. In addition, receiver operating characteristic analysis curves were computed to calculate the cutoff values of iron in the motor cortex in distinguishing patients and controls. To establish a best cutoff value, we considered a value that presented with the highest sum of sensitivity and specificity. Finally, a combined receiver operating characteristic was obtained with SWI and DTI measures [iron + {(1-FA) + ADC}].

Results

Subject Characteristics

Patients were in the age range of 32–76 years (mean, 54.41 ± 13.99 years), and controls were 45–75 years of age (mean, 56.8 ± 8.28 years). Patients and controls were comparable in age (P = .551) and sex (P = .492). The average age at onset of ALS was 51.94 years. The demographic and clinical information of the patients is shown in On-line Table 1.

Visual Rating Measurements of the Motor Cortex

Between the 2 observers in SWI, visual scoring for hypointensity showed excellent agreement for PBMC (κ = 0.97, P < .001), while other regions such as the caudate nucleus (κ = 0.75, P < .001), putamen (κ = 0.75, P < .001), and globus pallidus (κ = 0.7, P < .001) also revealed good interrater agreement.

Sensitivity and Specificity Analysis

The visual assessment of hypointensity scores in the PBMC was highly sensitive (91.15%) in differentiating patients with ALS from healthy controls while considering absent-versus-present groups. However, the specificity was less (13.35%) when the magnitude of hypointensity was considered this way. Similar analysis between the absent/mild to moderately present versus the markedly present group showed 100% specificity but very low sensitivity (20.55%). There was no statistically significant correlation among Fe scores in other GM regions.

Quantitation of Regional Iron Deposition in Gray Matter Structures

The regional assessment of iron content (micrograms iron/gram of tissue) in various gray matter regions revealed significantly increased iron deposition in the PBMC (P = .007) in patients with ALS compared with controls (Figs 2 and 3). However, the iron deposition in the anterior bank of the motor cortex, anterior bank of the sensory cortex, posterior bank of the sensory cortex, globus pallidus, putamen, and caudate nucleus, though higher than that in the control group, was not statistically significant (Table 1). One-way ANOVA of estimated means of iron values, and the visual rating score in the PBMC also revealed a significant difference between groups (P = .004).

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Distribution of iron content in the posterior bank of the motor cortex plotted for patients and controls. HC indicates healthy controls.

Fig 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 3.

Boxplot showing group comparison of iron content in the posterior banks of motor cortex in patients and controls. HC indicates healthy controls.

View this table:
  • View inline
  • View popup
Table 1:

Iron content (μg Fe/g of tissue) of each ROI in the ALS and control groupsa

Diffusion Measurements of the Corticospinal Tract

The mean values of FA and Dav for patients with ALS and controls at various levels of the CST are shown in Table 2. Patients with ALS showed lower FA values than controls along the CST in the pons (P = .001). A similar trend was observed for the medullary pyramid (Fig 4), though this did not survive after multiple comparisons. In addition, the Dav values were significantly elevated in the pons (P = .003) and pyramid (P = .011) (Fig 5). No significant correlation was found in any of the ROIs between the amount of iron deposition and FA values in the CST. A similar pattern was observed between Dav and iron values.

View this table:
  • View inline
  • View popup
Table 2:

Diffusion property measurement of corticospinal tract by ROI analysisa

Fig 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 4.

Boxplot showing group comparison of fractional anisotropy along the corticospinal tracts at the levels of pons and medulla. HC indicates healthy controls.

Fig 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 5.

Boxplot showing group comparison of directionally averaged mean diffusivity (×10−3 mm2/s) along the corticospinal tracts at the levels of the pons and medulla. HC indicates healthy controls.

Receiver Operating Characteristic Curve Analysis

The receiver operating characteristic curve analysis predicted the cutoff of iron in the PBMC and FA values. Identification of the greatest sum of sensitivity and specificity determined an iron value of ≥35 μg Fe/g of tissue as the best cutoff value for the PBMC, with a sum of sensitivity and specificity of 149% and area under the curve = 0.78 (95% CI, 0.61–0.94; P = .008). Of the 17 patients, 13 presented with an iron content of ≥35 μg Fe/g of tissue for the PBMC. Of the values of the 15 controls, only 4 were at or above the cutoff for the PBMC. When DTI measurements were added to SWI, only marginal improvement was observed in the area under the curve = 0.784 (95% CI, 0.62–0.95; P = .006) with a sum of sensitivity and specificity of 150.6% (Fig 6).

Fig 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 6.

Receiver operating characteristics curve for the combined SWI in the PBMC and DTI values in the CST.

Discussion

In this study, we qualitatively and quantitatively assessed the putative iron content in various gray matter structures, especially the motor cortex of the brain in patients with ALS in conjunction with microstructural changes along the CST by using SWI and DTI, respectively. A few earlier cross-sectional studies have investigated the phase differences between tissues in a number of regions of the human brain as a means of detecting iron abnormalities and CST degeneration by using MR imaging separately. To the best of our knowledge, no previous studies have performed the simultaneous assessment of brain iron content in the motor cortex and the changes in the CST by using SWI and DTI together.

It is well-known that degenerative brain disorders like Alzheimer disease,23 Parkinson disease,16 multiple sclerosis,24 and ALS have been associated with region-specific iron accumulation.25 Increased iron deposition in the motor cortex of patients with ALS has been proved in histologic analysis,26 MR imaging studies,17 and postmortem examinations.27 Conventional MR imaging sequences such as FLAIR,28 T2-weighted,29 proton-density weighted,30 and magnetization transfer imaging have revealed signal-intensity changes and a reduced magnetization transfer ratio31 in the internal capsule in patients with ALS. However, the clinical utility of these techniques in individual patient management is questionable.32 Advanced imaging techniques like MR spectroscopy33 and DTI have shown a significantly reduced NAA-to-creatine ratio and FA at various locations of CST, respectively,34 in patients with ALS. In ALS, the signal alteration in the deeper layers of the motor cortex is correlated with accumulation of iron-laden microglia. The microglial cells in the motor cortex play a vital role in maintaining iron homeostasis, and enhanced microglial iron accumulation leads to the pathologic changes in ALS. In addition, excessive iron deposition in the motor cortex is considered a marker of disruption in the regulatory pathways of iron in the brain. Approximately 20% of familial ALS is caused by mutations in the superoxide dismutase gene. Earlier observations confirmed such findings in which elevated levels of ferritin transcripts were found in the SOD1G93A mouse model.35 Moreover, lines of evidence indicate the presence of polymorphism in HFE genes and increased expression of the H63D variant of HFE genes with abnormal ion metabolism contributing to ALS pathology.36

Compared with other imaging sequences, SWI is more robust and has been shown to provide sensitive measures of iron on the order of micrograms iron/gram of tissue. Adachi et al17 proved the supremacy of SWI to detect the iron deposition in the precentral cortex in ALS. They described much lower signal intensity on SWI than on T2- and T2*-weighted images and proved the presence of Fe-laden microglia and macrophages in the precentral cortex after staining with antiferritin antibody. A more recent analysis of DTI data by using tract-based spatial statistics determined reduced FA at the distal portion of CST in patients with ALS compared with those with primary lateral sclerosis. Regional analysis of diffusion characteristics along the CST in ALS revealed a marked reduction of FA values at the levels of the internal capsule and pyramids.37

We performed the visual assessment of hypointensities in patients with ALS as a measure of iron deposition in ALS, to analyze its clinical utility as a quick visual imaging tool to differentiate patients with ALS from age-matched healthy individuals. The hypointensity scoring in bilateral PBMC regions was found to be highly sensitive in differentiating patients with ALS from individuals with normal brains. The overall specificity was, however, low, but it improved once severe hypointensity was considered for the diagnosis of ALS. We also found no significant difference between the visual rating of Fe content in patients with ALS and controls in the caudate nucleus, putamen, and globus pallidus regions. To confirm these results and to make it more objective, we performed a quantitative analysis of iron content in terms of phase shift values in the motor cortex and basal ganglia regions. Our observations of significantly increased iron accumulation in the motor cortex of patients with ALS are in agreement with recent findings.12 However, no significant differences were noted between patients with ALS and controls in other regions, including the anterior motor and sensory cortices, posterior sensory cortex, globus pallidus, putamen, and caudate nucleus. Yu et al,12 who used the phase shift values of SWI by a 3T scanner, found that there was no difference in the iron levels in the globus pallidus, putamen, head of caudate nucleus, substantia nigra, and red nucleus in patients with ALS compared with controls. In contrast, a previous study by R2* mapping reported increased iron deposition in the caudate nucleus of patients with ALS compared with age- and sex-matched controls.1

Besides iron deposition in the PBMC, there were significantly reduced FA and increased Dav in the CST of patients with ALS compared with controls,5,38,39 and the pattern was maintained from the pons to the medulla. When one considered multiple comparisons, the significance of FA in the medulla disappeared due to lack of statistical power. A previous report showed significant changes in FA and Dav in the bulbar-onset groups and correlated FA changes with measures of disease severity and the upper motor neuron index.40 It is evident that FA is highly variable among the sections of the pons and medulla.39 Increased Dav probably detects striking and chronic changes at these levels.

No correlation was found between regional iron values and any of the diffusion characteristics. The exact cause of this remains unexplained; however, they might represent relatively independent processes of degeneration within the natural course of the disease progression. Hence, we think that combined assessment of iron deposition and diffusion characteristics might be useful as a potential biomarker for the diagnosis and characterization of motor neuron diseases. However, this needs confirmation with future prospective studies.

The present study has a few limitations. These results were established in a relatively small cohort of clinically probable cases of ALS in this retrospective study, but a higher sample size would have contributed further to the validity. Second, this was a cross-sectional image-analysis study of patients with various clinical presentations in differing stages of the disease; hence, it is unable to provide details on the dynamic changes expected in correlation with the clinical progression of the disease. The data were from a 1.5T scanner, and better results could be expected on a 3T scanner by improving the SNR and susceptibility effects. Our results need to be confirmed in future prospective studies by using larger samples.

Conclusions

This study demonstrates the usefulness of analysis of SWI and DTI in estimating motor cortex iron deposition and CST changes in patients with ALS. Quantitative estimation showed abnormal brain iron deposition in the posterior bank of the motor cortex in patients with ALS. The diffusion characteristics suggest altered microstructural organization of the CST at different brain stem levels. However, no statistically significant correlation was found among these processes, suggesting their possible independent evolution. Hence, a combined analysis of them might provide meaningful insights into the pathophysiologic changes in ALS and can serve as an in vivo objective biomarker for the diagnosis of ALS. Moreover, combining multimodal neuroimaging techniques along with clinical, genetic, and pathologic markers is a promising way to understand the underlying disease mechanisms, which might lead to the development of more robust biomarkers for the diagnosis and staging of this disease. However, future longitudinal prospective studies are warranted to prove this.

Acknowledgments

We thank Dr Ravi Prasad Varma for his valuable suggestions on the statistical analysis.

References

  1. 1.↵
    1. Langkammer C,
    2. Enzinger C,
    3. Quasthoff S, et al
    . Mapping of iron deposition in conjunction with assessment of nerve fiber tract integrity in amyotrophic lateral sclerosis. J Magn Reson Imaging 2010;31:1339–45 doi:10.1002/jmri.22185 pmid:20512885
    CrossRefPubMed
  2. 2.↵
    1. Kiernan MC,
    2. Vucic S,
    3. Cheah BC, et al
    . Amyotrophic lateral sclerosis. Lancet 2011;377:942–55 doi:10.1016/S0140-6736(10)61156-7 pmid:21296405
    CrossRefPubMed
  3. 3.↵
    1. Petri S,
    2. Körner S,
    3. Kiaei M
    . Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS. Neurol Res Int 2012;2012:878030 doi:10.1155/2012/878030 pmid:23050144
    CrossRefPubMed
  4. 4.↵
    1. Jomova K,
    2. Vondrakova D,
    3. Lawson M, et al
    . Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 2010;345:91–104 doi:10.1007/s11010-010-0563-x pmid:20730621
    CrossRefPubMed
  5. 5.↵
    1. Toosy AT,
    2. Werring DJ,
    3. Orrell RW, et al
    . Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003;74:1250–57 doi:10.1136/jnnp.74.9.1250 pmid:12933929
    Abstract/FREE Full Text
  6. 6.↵
    1. Aoki S,
    2. Iwata NK,
    3. Masutani Y, et al
    . Quantitative evaluation of the pyramidal tract segmented by diffusion tensor tractography: feasibility study in patients with amyotrophic lateral sclerosis. Radiat Med 2005;23:195–99 pmid:15940067
    PubMed
  7. 7.↵
    1. Oshiro S,
    2. Morioka MS,
    3. Kikuchi M
    . Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Adv Pharmacol Sci 2011;2011:378278 doi:10.1155/2011/378278 pmid:22013437
    CrossRefPubMed
  8. 8.↵
    1. Péran P,
    2. Hagberg G,
    3. Luccichenti G, et al
    . Voxel-based analysis of R2* maps in the healthy human brain. J Magn Reson Imaging 2007;26:1413–20 doi:10.1002/jmri.21204 pmid:18059009
    CrossRefPubMed
  9. 9.↵
    1. Jensen JH,
    2. Szulc K,
    3. Hu C, et al
    . Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn Reson Med 2009;61:481–85 doi:10.1002/mrm.21823 pmid:19161168
    CrossRefPubMed
  10. 10.↵
    1. Bartzokis G,
    2. Tishler TA,
    3. Lu PH, et al
    . Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 2007;28:414–23 doi:10.1016/j.neurobiolaging.2006.02.005 pmid:16563566
    CrossRefPubMed
  11. 11.↵
    1. Harder SL,
    2. Hopp KM,
    3. Ward H, et al
    . Mineralization of the deep gray matter with age: a retrospective review with susceptibility-weighted MR imaging. AJNR Am J Neuroradiol 2008;29:176–83 doi:10.3174/ajnr.A0770 pmid:17989376
    Abstract/FREE Full Text
  12. 12.↵
    1. Yu J,
    2. Qi F,
    3. Wang N, et al
    . Increased iron level in motor cortex of amyotrophic lateral sclerosis patients: an in vivo MR study. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:357–61 doi:10.3109/21678421.2014.906618 pmid:24809595
    CrossRefPubMed
  13. 13.↵
    1. Haacke EM,
    2. Xu Y,
    3. Cheng YC, et al
    . Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612–28 doi:10.1002/mrm.20198 pmid:15334582
    CrossRefPubMed
  14. 14.↵
    1. Haacke EM,
    2. Ayaz M,
    3. Khan A, et al
    . Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 2007;26:256–64 doi:10.1002/jmri.22987 pmid:17654738
    CrossRefPubMed
  15. 15.↵
    1. Haacke EM,
    2. Makki M,
    3. Ge Y, et al
    . Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009;29:537–44 doi:10.1002/jmri.21676 pmid:19243035
    CrossRefPubMed
  16. 16.↵
    1. Wu SF,
    2. Zhu ZF,
    3. Kong Y, et al
    . Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI. Eur Rev Med Pharmacol Sci 2014;18:2605–08 pmid:25317792
    PubMed
  17. 17.↵
    1. Adachi Y,
    2. Sato N,
    3. Saito Y, et al
    . Usefulness of SWI for the detection of iron in the motor cortex in amyotrophic lateral sclerosis. J Neuroimaging 2015;25:443–51 doi:10.1111/jon.12127 pmid:24888543
    CrossRefPubMed
  18. 18.↵
    1. Thomas B,
    2. Somasundaram S,
    3. Thamburaj K, et al
    . Clinical applications of susceptibility weighted MR imaging of the brain: a pictorial review. Neuroradiology 2008;50:105–16 doi:10.1007/s00234-007-0316-z pmid:17929005
    CrossRefPubMed
  19. 19.↵
    1. Brooks BR
    . El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis: Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 1994;124(suppl):96–107 doi:10.1016/0022-510X(94)90191-0 pmid:7807156
    CrossRefPubMed
  20. 20.↵
    1. Chiò A,
    2. Calvo A,
    3. Moglia C, et al
    . Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011;82:740–46 doi:10.1136/jnnp.2010.235952 pmid:21402743
    Abstract/FREE Full Text
  21. 21.↵
    1. Roche JC,
    2. Rojas-Garcia R,
    3. Scott KM, et al
    . A proposed staging system for amyotrophic lateral sclerosis. Brain 2012;135:847–852 doi:10.1093/brain/awr351 pmid:22271664
    Abstract/FREE Full Text
  22. 22.↵
    1. Hirayama K,
    2. Tsubaki T,
    3. Toyokura Y, et al
    . The representation of the pyramidal tract in the internal capsule and basis pedunculi: a study based on three cases of amyotrophic lateral sclerosis. Neurology 1962;12:337–42 doi:10.1212/WNL.12.5.337 pmid:13907643
    FREE Full Text
  23. 23.↵
    1. Zhou B,
    2. Li S,
    3. Huijin H, et al
    . The evaluation of iron content in Alzheimer's disease by magnetic resonance imaging: phase and R2* methods. Adv Alzheimer Dis 2013;2:51–59 doi:10.4236/aad.2013.22007
    CrossRef
  24. 24.↵
    1. Ropele S,
    2. de Graaf W,
    3. Khalil M, et al
    . MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging 2011;34:13–21 doi:10.1002/jmri.22590 pmid:21698703
    CrossRefPubMed
  25. 25.↵
    1. Zecca L,
    2. Youdim MB,
    3. Riederer P, et al
    . Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004;5:863–73 doi:10.1038/nrn1537 pmid:15496864
    CrossRefPubMed
  26. 26.↵
    1. Kwan JY,
    2. Jeong SY,
    3. Van Gelderen P, et al
    . Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 Tesla MRI and pathology. PLoS One 2012;7:e35241 doi:10.1371/journal.pone.0035241 pmid:22529995
    CrossRefPubMed
  27. 27.↵
    1. Oba H,
    2. Araki T,
    3. Ohtomo K, et al
    . Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993;189:843–46 doi:10.1148/radiology.189.3.8234713 pmid:8234713
    CrossRefPubMed
  28. 28.↵
    1. Cheung G,
    2. Gawel MJ,
    3. Cooper PW, et al
    . Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 1995;194:263–70 doi:10.1148/radiology.194.1.7997565 pmid:7997565
    CrossRefPubMed
  29. 29.↵
    1. Hofmann E,
    2. Ochs G,
    3. Pelzl A, et al
    . The corticospinal tract in amyotrophic lateral sclerosis: an MRI study. Neuroradiology 1998;40:71–75 doi:10.1007/s002340050543 pmid:9541915
    CrossRefPubMed
  30. 30.↵
    1. Hecht MJ,
    2. Fellner F,
    3. Fellner C, et al
    . MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1- and proton-density-weighted images. J Neurol Sci 2001;186:37–44 doi:10.1016/S0022-510X(01)00503-2 pmid:11412870
    CrossRefPubMed
  31. 31.↵
    1. Kato Y,
    2. Matsumura K,
    3. Kinosada Y, et al
    . Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements. AJNR Am J Neuroradiol 1997;18:1541–47 pmid:9296197
    Abstract
  32. 32.↵
    1. Cudkowicz M,
    2. Qureshi M,
    3. Shefner J
    . Measures and markers in amyotrophic lateral sclerosis. NeuroRx 2004;1:273–83 doi:10.1602/neurorx.1.2.273 pmid:15717028
    Abstract/FREE Full Text
  33. 33.↵
    1. Mitsumoto H,
    2. Ulug AM,
    3. Pullman SL, et al
    . Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007;68:1402–10 doi:10.1212/01.wnl.0000260065.57832.87 pmid:17452585
    Abstract/FREE Full Text
  34. 34.↵
    1. Iwata NK,
    2. Kwan JY,
    3. Danielian LE, et al
    . White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 2011;134(pt 9):2642–55 doi:10.1093/brain/awr178 pmid:21798965
    Abstract/FREE Full Text
  35. 35.↵
    1. Olsen MK,
    2. Roberds SL,
    3. Ellerbrock BR, et al
    . Disease mechanisms revealed by transcription profiling in SOD1–G93A transgenic mouse spinal cord. Ann Neurol 2001;50:730–40 doi:10.1002/ana.1252 pmid:11761470
    CrossRefPubMed
  36. 36.↵
    1. Restagno G,
    2. Lombardo F,
    3. Ghiglione P, et al
    . HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin. J Neurol Neurosurg Psychiatry 2007;78:327 doi:10.1136/jnnp.2006.092338 pmid:17308297
    FREE Full Text
  37. 37.↵
    1. Jacob S,
    2. Finsterbusch J,
    3. Weishaupt JH, et al
    . Diffusion tensor imaging for long-term follow-up of corticospinal tract degeneration in amyotrophic lateral sclerosis. Neuroradiology 2003;45:598–600 doi:10.1007/s00234-003-1014-0 pmid:12904924
    CrossRefPubMed
  38. 38.↵
    1. Wang S,
    2. Poptani H,
    3. Bilello M, et al
    . Diffusion tensor imaging in amyotrophic lateral sclerosis: volumetric analysis of the corticospinal tract. AJNR Am J Neuroradiol 2006;27:1234–38 pmid:16775271
    Abstract/FREE Full Text
  39. 39.↵
    1. Hong YH,
    2. Lee KW,
    3. Sung JJ, et al
    . Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis. J Neurol Sci 2004;227:73–78 doi:10.1016/j.jns.2004.08.014 pmid:15546594
    CrossRefPubMed
  40. 40.↵
    1. Sage CA,
    2. Peeters RR,
    3. Görner A, et al
    . Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage 2007;34:486–99 doi:10.1016/j.neuroimage.2006.09.025 pmid:17097892
    CrossRefPubMed
  • Received March 14, 2015.
  • Accepted after revision July 9, 2015.
  • © 2016 by American Journal of Neuroradiology
View Abstract
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 37 (2)
American Journal of Neuroradiology
Vol. 37, Issue 2
1 Feb 2016
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Potential Biomarker in Amyotrophic Lateral Sclerosis: Can Assessment of Brain Iron Deposition with SWI and Corticospinal Tract Degeneration with DTI Help?
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
R. Sheelakumari, M. Madhusoodanan, A. Radhakrishnan, G. Ranjith, B. Thomas
A Potential Biomarker in Amyotrophic Lateral Sclerosis: Can Assessment of Brain Iron Deposition with SWI and Corticospinal Tract Degeneration with DTI Help?
American Journal of Neuroradiology Feb 2016, 37 (2) 252-258; DOI: 10.3174/ajnr.A4524

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
A Potential Biomarker in Amyotrophic Lateral Sclerosis: Can Assessment of Brain Iron Deposition with SWI and Corticospinal Tract Degeneration with DTI Help?
R. Sheelakumari, M. Madhusoodanan, A. Radhakrishnan, G. Ranjith, B. Thomas
American Journal of Neuroradiology Feb 2016, 37 (2) 252-258; DOI: 10.3174/ajnr.A4524
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Acknowledgments
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Assessment of Iron Deposition in the Brain in Frontotemporal Dementia and Its Correlation with Behavioral Traits
  • Crossref (28)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases
    Parsa Ravanfar, Samantha M. Loi, Warda T. Syeda, Tamsyn E. Van Rheenen, Ashley I. Bush, Patricia Desmond, Vanessa L. Cropley, Darius J. R. Lane, Carlos M. Opazo, Bradford A. Moffat, Dennis Velakoulis, Christos Pantelis
    Frontiers in Neuroscience 2021 15
  • Cerebral Iron Deposition in Neurodegeneration
    Petr Dusek, Tim Hofer, Jan Alexander, Per M. Roos, Jan O. Aaseth
    Biomolecules 2022 12 5
  • No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases
    Douglas B. Kell, Etheresia Pretorius
    Biological Reviews 2018 93 3
  • Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?
    Khalil Mallah, Christine Couch, Davis M. Borucki, Amer Toutonji, Mohammed Alshareef, Stephen Tomlinson
    Frontiers in Immunology 2020 11
  • Crosstalk Between the Gut Microbiota and the Brain: An Update on Neuroimaging Findings
    Ping Liu, Guoping Peng, Ning Zhang, Baohong Wang, Benyan Luo
    Frontiers in Neurology 2019 10
  • Quantitative Susceptibility Mapping: Technical Considerations and Clinical Applications in Neuroimaging
    Selvadasan Vinayagamani, R Sheelakumari, Sekar Sabarish, Santhakumar Senthilvelan, Roopa Ros, Bejoy Thomas, Chandrasekharan Kesavadas
    Journal of Magnetic Resonance Imaging 2021 53 1
  • Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis
    Miguel Mazón, Juan Francisco Vázquez Costa, Amadeo Ten-Esteve, Luis Martí-Bonmatí
    Frontiers in Neuroscience 2018 12
  • Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis
    Juan F. Vázquez‐Costa, Miguel Mazón, Joan Carreres‐Polo, David Hervás, Jordi Pérez‐Tur, Luis Martí‐Bonmatí, Teresa Sevilla
    Acta Neurologica Scandinavica 2018 137 2
  • Assessment of Iron Deposition in the Brain in Frontotemporal Dementia and Its Correlation with Behavioral Traits
    R. Sheelakumari, C. Kesavadas, T. Varghese, R.M. Sreedharan, B. Thomas, J. Verghese, P.S. Mathuranath
    American Journal of Neuroradiology 2017 38 10
  • Diagnostic and Prognostic Value of Conventional Brain MRI in the Clinical Work-Up of Patients with Amyotrophic Lateral Sclerosis
    Giovanni Rizzo, Anna Marliani, Stella Battaglia, Luca Albini Riccioli, Silvia De Pasqua, Veria Vacchiano, Rossella Infante, Patrizia Avoni, Vincenzo Donadio, Massimiliano Passaretti, Ilaria Bartolomei, Fabrizio Salvi, Rocco Liguori
    Journal of Clinical Medicine 2020 9 8

More in this TOC Section

  • Diagnostic Neuroradiology of Monoclonal Antibodies
  • ML for Glioma Molecular Subtype Prediction
  • Segmentation of Brain Metastases with BLAST
Show more Adult Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editors Choice
  • Fellow Journal Club
  • Letters to the Editor

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • Special Collections

Resources

  • News and Updates
  • Turn around Times
  • Submit a Manuscript
  • Author Policies
  • Manuscript Submission Guidelines
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Submit a Case
  • Become a Reviewer/Academy of Reviewers
  • Get Peer Review Credit from Publons

Multimedia

  • AJNR Podcast
  • AJNR SCANtastic
  • Video Articles

About Us

  • About AJNR
  • Editorial Board
  • Not an AJNR Subscriber? Join Now
  • Alerts
  • Feedback
  • Advertise with us
  • Librarian Resources
  • Permissions
  • Terms and Conditions

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire